US › Healthcare

Trinity Biotech plc (TRIB)

US · Healthcare · Medical Devices

$11.00-1.12%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$11.1M
Revenue YoY
-27.0%
Net profit
$-17.5M
Profit YoY
-266.9%
EPS
$-0.40
EPS estimate
$0.00
Net margin
-157.8%

Key statistics

Market cap
$7.5M
Forward P/E
4.5
P/B
5.11
Book value
$-115.42
EPS (TTM)
$-60.00
52-week high
$14.17
52-week low
$0.31
50-day MA
$14.80
200-day MA
$21.65
Beta
0.99

Analyst view

Analysts rate Trinity Biotech plc a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $3.00.

Shareholding

Insiders
16.58%
Institutions
6.07%

Largest institutional holders

FundStake
Hunter Associates Inc.3.27%
Yorkville Advisors Global, LP1.11%
Williams & Novak LLC0.69%
Virtu Financial LLC0.13%
Moss Adams Wealth Advisors LLC0.13%
Integrys Wealth Advisors LLC0.12%
CAMBRIDGE Invest RESEARCH ADVISORS, INC.0.11%
Becker Capital0.09%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Trinity Biotech plc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.